We describe two improved methods for determination of erythrocyte glucose-6-phosphate dehydrogenase activity. One method is an "enzyme-linked" procedure in which an excess of 6-phosphogluconate dehydrogenase is used to produce two moles of NADPHfor each mole of glucose-6-phosphate oxidized. In the other method 2,3-diphosphoglycerate is used to inhibit the variable contribution of endogenous 6-phosphogluconate dehydrogenase to glucose-6-phosphate dehydrogenase activity in erythrocyte lysates. These assays require 100 tI of blood and are performed on a centrifugal analyzer in a final reaction volume of 410 0 at 37 #{176}C.
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We describe two improved methods for determination of erythrocyte glucose-6-phosphate dehydrogenase activity. One method is an "enzyme-linked" procedure in which an excess of 6-phosphogluconate dehydrogenase is used to produce two moles of NADPHfor each mole of glucose-6-phosphate oxidized. In the other method 2,3-diphosphoglycerate is used to inhibit the variable contribution of endogenous 6-phosphogluconate dehydrogenase to glucose-6-phosphate dehydrogenase activity in erythrocyte lysates. These assays require 100 tI of blood and are performed on a centrifugal analyzer in a final reaction volume of 410 0 at 37 #{176}C.
NADPH formation is monitored at 340 nm. Hemoglobin is measured as oxyhemoglobin in the same reaction mixture used to determine enzyme activity by changing the wavelength to 550 nm. Results are expressed as international units of glucose-6-phosphate dehydrogenase activity per gram of hemoglobin. The coefficient of correlation between "enzyme-linked" assay and "standard" assay was .992, the slope of the regression line was 1.07, and the intercept was at -0.76. When results of the "enzyme-linked" assay were compared to those of the "nonlinked" assay with added 2,3-diphosphoglycerate, the slope of the regression line was .994, the intercept 0.109, and the correlation coefficient .994. The assay usually used to determine GGPD activity in erythrocytes involves subtracting the rate of NADPH production with only 6-phosphogluconic acid as a substrate from the rate of NADPH production when a mixture of fi-phosphogluconic acid and glucose-6-phosphate is the substrate (7, 8) . This subtraction process can produce an error that increases with decreasing G6PD activity (9). In the following description, this method is designated the "standard" assay.
An assay that does not have this undesirable attribute involves adding excess 6PGD to a reaction mixture containing glucose-6-phosphate and NADP (8, 10) . This excess of 6PGD catalyzes the conversion of all 6-phosphogluconic acid to ribulose-5-phosphate, producing an additional mole of NADPH. Here, we designate this the "enzyme-linked" assay. A third method for measuring G6PD activity is based on the work of Yoshida and Lin, who described an inhibition of 6PGD by 2, 3-diphosphoglycerate (11, 12) . Based on this observation a one-step assay for G6PD has been developed in which glucose-6-phosphate, NADP and 2,3-diphosphoglycerate are used. In this assay the conversion of 6-phosphogluconic acid to ribulose-5-phosphate is inhibited, and only 1 mol of NADPH is generated for each mole of glucose-6-phosphate oxidized. Here we call this the "nonlinked" assay.
Automated methods are described for quantitatively determining erythrocyte G6PD activity, which increase the speed, precision, accuracy, and economy of the assay, and incorporate new techniques.
Materials and Methods

Instrumentation
A CentrifiChem centrifugal analyzer (Union Carbide Corp., Tarrytown, N. Y. 10591) was used to measure reaction rates. The 340-nm filter was calibrated with NADH solutions. The 540-nm and the 550-nm filters were calibrated for oxyhemoglobin absorbance by standardization with a Beckman DB-GT spectrophotometer.
Samples
Blood was obtained in evacuated tubes (BectonDickinson, Rutherford, N. J. 07070) containing tripotassium ethylenediaminetetraacetate as anticoagulant or in capillary tubes (Clay Adams, Parsippany, N. J. 07054) containing ammonium heparin as anticoagulant.
Reagents
The following reagents were all obtained from The buffer and lysing solutions were stable for three months at 4 #{176}C. The remaining working reagents were prepared freshly each day from frozen stock solutions of glucose-6-phosphate (0.1 mol/liter), 6-phosphogluconic acid (0.1 mol/liter), and NADP (0.05mol/liter)in water.
Procedure
Preparation of whole-blood lysate:
Mix a drop (about 0.1 ml) of blood with 0.5 ml of digitonin solution and allow the mixture to stand at room temperature for 10 mm for complete hemolysis.
Assay procedure: With a CentrifiChem dilutor, wash 10 zl of lysate with 50 sl of diluent (water) into the sample cavities, and pipet 350 d of working reagent cavities of the transfer disc. The zero cuvette contains water. For the reagent blank, substitute water for lysate. Run the reaction at 37 #{176}C, and measure absorbance at 340 nm.
In the "nonlinked" and "standard" assays we took initial readings at 3 mm, in the "enzyme-linked" assay at 8 mm. Unless otherwise indicated, we took two subsequent readings at 2-mm intervals with the CentrifiChem mode set on "Rate." The interference filter was then changed from 340-nm to 550-nm and the value for absorbance at 550-nm was stored and subsequently referenced to water. 3. Standard assay: Reaction rates in the presence of both 6-phosphogluconic acid and glucose-6-phosphate, and of 6-phosphogluconic acid alone were measured and normalized with respect to hemoglobin. These rates were subtracted and the above formula was used to calculate international units per gram of hemoglobin.
Calculations
Results
Figure
1 (upper curve) shows the influence of 6PGD on the rate of production of NADPH in the linked assay system for G6PD. Without added 6PGD, the reaction rate increased slowly over 20 mm (middle curve). As the upper curve shows, on addition of exogenous 6PGD, a lag phase of about 6-8 mm appears, followed by a reaction for which the rate is linear over at least a 0.4 A range. The reaction rate for the linear portion of the linked assay was 1.7 times that during the initial 2.5 mm of the assay without added 6PGD. Figure 2 shows the relationship between values for G6PD activity in lysates of erythrocytes, as determined by the standard assay and by the enzymelinked assay. For the 25 samples so compared, the slope of the regression line was 1.07 with an intercept of -0.76 and a correlation coefficient of .992. The mean value of G6PD activity as determined by the standard assay was 9.4 U/g hemoglobin, and by the enzyme-linked assay it was 9.3 U/g hemoglobin. Figure 1 (lower curve) shows the influence of 2,3-diphosphoglycerate on the rate of production of NADPH in the nonlinked assay system for GGPD. The reaction rate without added 2,3-diphosphoglycerate (middle curve) increased slowly throughout the time it was observed. Addition of exogenous 2,3-diphosphoglycerate (lower curve) resulted in a decreased reaction rate, which was linear over at least a 0.3 A range. For the particular example illustrated, the reaction rate for the nonlinked assay with added 2,3-diphosphoglycerate was 0.92-fold that during the initial 2.5 mm of the nonlinked assay without 2,3-diphosphoglycerate. Figure 3 shows the relationship between values for G6PD activity in erythrocyte lysates, as determined by the enzyme-linked assay and by the nonlinked assay with added 2,3-diphosphoglycerate. For the 50 samples so compared, the slope of the regression line was 0.994 with an intercept of 0. 109 and a correlation coefficient of 0.994. The mean value of G6PD activity as determined by the enzyme-linked assay was 9.14 U/g hemoglobin and by the nonlinked assay with added 2,3-diphosphoglycerate it was 8.97 U/g hemoglobin.
The influence of 2,3-diphosphoglycerate on the activity of 6PGD in erythrocyte lysates is shown in Table 1 . The activity of this enzyme was decreased by about 71% and 86%, respectively, by 4 and 10 mmol of 2,3-diphosphoglycerate per liter under the conditions specified. Within-run precision of the enzyme-linked assay and the nonlinked assay with 2,3-diphosphoglycerate was determined by analysis of duplicates ( Table 2 ). The mean value of G6PD activity of these specimens was 9.90 U/g hemoglobin and the standard deviation calculated from the differences was 0.17. This corresponds to a coefficient of variation for specimens within the normal range of 1.72%. Similarly, withinrun precision of the nonlinked assay containing 2,3-diphosphoglycerate, determined by analysis of duplicates, yielded a mean value of G6PD activity of 10.75 U/g hemoglobin (SD, 0.31; CV, 2.88%).
Discussion
G6PD activity in erythrocyte lysates cannot be determined accurately with only glucose-6-phosphate and NADP used as substrates, because the endogenous 6PGD in such lysates utilizes 6-phosphogluconic acid and produces an additional mole of NADPH. Without exogenous 6PGD a prolonged lag phase would be observed during which the rate of production of NADPH would increase continuously until the concentration of 6-phosphogluconic acid in the reaction mixture reached a steady state.
Analytical procedures
for the quantitative determination of G6PD in erythrocyte lysates have been developed that correct for the variable contribution of 6PGD to the measured total enzyme activity. Two separate approaches to this problem have been proposed. In one, G6PD activity is determined in the presence of a large excess of 6PGD (8, 10) . In this method each mole of glucose-6-phosphate oxidized yields 2 mol of NADPH. In the other, the enzyme activity of the endogenous 6PGD is determined with 6-phosphogluconic acid and this activity is subtracted from the combined activities determined with 6-phosphogluconic acid and glucose-6-phosphate (8).
Glock and McLean observed good agreement between the results obtained with these two assay systems (8), as did we (r = 0.992).
In the enzyme-linked assay for determination of G6PD activity in erythrocyte lysates, a preparation of 6PGD obtained from yeast is used that contains trace amounts of G6PD (0.007% of the 6PGD activity). We used different lots of this commercially avail- able enzyme during the past two years and all proved adequate for the determination of G6PD activity in erythrocyte lysates. Thus the concern expressed by Lowe et al. (13) regarding the availability of highly purified 6PGD preparations for use in the single-step assay specific for G6PD does not appear warranted.
With the enzyme-linked assay we have described, a lag period of about 8 mm is noted (Figure 1) . A 2.5-fold increase in 6PGD concentration above that usually used in the enzyme-linked assay did not shorten this lag phase. These results demonstrate that the lag phase is independent of the concentration of 6PGD and suggest that it depends on the rate of hydrolysis of 6-phosphogluconolactone to 6-phosphogluconic acid. The hydrolysis of 6-phosphogluconolactone occurs both nonenzymatically and in the presence of 6-phosphogluconolactonase.
It is not known whether this enzyme is present in appreciable quantities in human erythrocytes.
The half-life of nonenzymatic hydrolysis of 6-phosphogluconolactone has been reported by Horecker and Smyrniotis (14) as 1.5 mm and by Kawada et al. (15) as about 20 mm. Since neither group specified the temperature, it is not possible to determine whether these results are discrepant. The availability of purified 6-phosphogluconolactonase (EC 3.1.1.31) could possibly result in an assay for G6PD with a shortened lag phase.
An alternative approach to correct for the variable contribution of 6PGD to GGPD activity in erythrocyte lysates is based on inhibition of endogenous GPGD. Yoshida and Lin (11) have shown that 2,3-diphosphoglycerate is a competitive inhibitor of 6-phosphogluconic acid in the reaction catalyzed by 6PGD. In contrast, 2,3-diphosphoglycerate did not inhibit purified human G6PD at concentrations as
